《The 21st century population-energy-climate nexus》

  • 来源专题:能源战略信息监测
  • 编译者: giecinfo
  • 发布时间:2016-03-14
  • World population is projected to reach 10.9 billion by 2100, yet nearly one-fifth of the world's current 7.2 billion live without access to electricity. Though universal energy access is desirable, a significant reduction in fossil fuel usage is required before mid-century if global warming is to be limited to <2 °C. Here we quantify the changes in the global energy mix necessary to address population and climate change under two energy-use scenarios, finding that renewable energy production (9% in 2014) must comprise 87–94% of global energy consumption by 2100. Our study suggests >50% renewable energy needs to occur by 2028 in a <2 °C warming scenario, but not until 2054 in an unconstrained energy use scenario. Given the required rate and magnitude of this transition to renewable energy, it is unlikely that the <2 °C goal can be met. Focus should be placed on expanding renewable energy as quickly as possible in order to limit warming to 2.5–3 °C.

相关报告
  • 《Empires of the East: The Return of Great Power Politics in the 21st Century》

    • 来源专题:科学技术史学科动态
    • 发布时间:2016-03-14
    • Thursday, March 10, 2016 Time Noon Location 206 Ingraham Hall Description This lecture will demonstrate that in much of Asia –and specifically in South Asia–empires were a normal, and often prevalent, form of political organization throughout history but in the 20th century nearly disappeared and now, in the 21st century, are re-emerging in new but historically recognizable forms.
  • 《12月21日_OSANG和Nexus Dx合作生产COVID-19试剂盒》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2021-01-29
    • Accesswire网站12月21日消息称,医疗级诊断测试和设备的全球制造商OSANG Healthcare公司以及SphingoTec集团旗下的Nexus公司宣布,由Nexus位于圣地亚哥的工厂生产OSANG的“GeneFinder(R)COVID-19 Plus RealAmp试剂盒”。 美国政府认为进入了冬季后,COVID-19/A&B流感组合测试至关重要。OSANG的测试是为了检测SARS-CoV-2,该测试通过一个基于基因的逆转录反应和实时聚合酶链反应(PCR)测试过程,可以在短短两个小时内提供96个测试结果,使其适合紧急状态和即时护理等情况。该公司还开发了一种可以在40分钟内得出唾液样本结果的产品。OSANG公司计划分发PCR诊断试剂盒用于移民检疫。该公司正计划在美国不同城市的机场供应诊断试剂盒,目前正在向美国食品和药物管理局(FDA)申请该PCR快速诊断试剂盒的紧急使用权(EUA)。 原文链接:https://www.accesswire.com/621788/OSANG-Healthcare-Co-Ltd-and-Nexus-Dx-Inc-Initiated-Partnership-for-US-Manufacturing-of-GeneFinderR-COVID-19-Plus-RealAmp-Kit